Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Pfizer Inc (PFE)

Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
MO
2 Large-Cap Stocks on Our Watchlist and 1 We Brush Off StockStory - Wed Feb 18, 10:42PM CST

2 Large-Cap Stocks on Our Watchlist and 1 We Brush Off

MO : 67.57 (-0.62%)
FISV : 61.47 (-0.10%)
PFE : 26.65 (-0.78%)
Pfizer’s BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer Business Wire - Tue Feb 17, 5:45AM CST

BREAKWATER trial Cohort 3 analysis demonstrated statistically significant and clinically meaningful improvement in progression-free survival in BRAF V600E -mutant metastatic colorectal...

PFE : 26.65 (-0.78%)
Pfizer Inc_ logo sign-by JHVEPhoto via iStock
Pfizer Reports Strong Earnings Outlook - Unusual Call Options Activity Shows Investors are Bullish Barchart - Wed Feb 11, 12:30PM CST

Pfizer reported strong earnings and earnings guidance. Large, unusual call option activity today, as noted in a Barchart report, indicates investors are bullish.

PFE : 26.65 (-0.78%)
PFE
5 Revealing Analyst Questions From Pfizer’s Q4 Earnings Call StockStory - Mon Feb 9, 11:37PM CST

5 Revealing Analyst Questions From Pfizer’s Q4 Earnings Call

PFE : 26.65 (-0.78%)
OPTIONS TRADING open book on table by One Photo via Shutterstock
Unusual Options Activity Alert: 3 Stocks Setting Up for Major Profit Potential Barchart - Fri Feb 6, 12:35PM CST

Volatility returned to markets yesterday, triggering a tech rout. Among the unusually active options on Thursday were 278 calls and puts with Vol/OI ratios of 15 or higher. Among them, these 3 stocks offer...

MSTR : 131.05 (+1.24%)
VFC : 21.23 (+2.02%)
QCOM : 142.88 (+1.14%)
ETSY : 52.18 (+8.39%)
LOGI : 90.04 (+0.75%)
NVO : 47.42 (-2.13%)
LLY : 1,009.52 (-1.34%)
PFE : 26.65 (-0.78%)
FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need Business Wire - Fri Feb 6, 5:45AM CST

Submission is to expand HYMPAVZI indication to the treatment of hemophilia A or B patients 6 years and older with inhibitors, and pediatric patients (ages 6 to 11) without inhibitors ...

PFE : 26.65 (-0.78%)
Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans Business Wire - Thu Feb 5, 6:09PM CST

Program offers significant savings on over 30 brands spanning women’s health, migraine, arthritis, rare disease and more Affirms Pfizer’s commitment...

PFE : 26.65 (-0.78%)
MarketBeat.com
Pfizer Pops on Q4 Results—But This May Be the Catalyst That Matters Most MarketBeat - Thu Feb 5, 4:22PM CST

Pfizer stock jumped after a strong earnings beat and positive GLP-1 data, but investors may be overlooking a powerful oncology and AI-driven growth story.

NVDA : 189.82 (+1.02%)
LLY : 1,009.52 (-1.34%)
PFE : 26.65 (-0.78%)
Traders Michael Smyth, left, and Neal Catania work on the floor of the New York Stock Exchange, Tuesday, Feb. 3, 2026. (AP Photo/Richard Drew)
More drops for technology stocks weigh on Wall Street Associated Press - Wed Feb 4, 4:50PM CST

More drops for technology stocks weighed on Wall Street

NVDA : 189.82 (+1.02%)
GOLD : 58.82 (+0.60%)
GOOGL : 314.98 (+4.01%)
AAPL : 264.58 (+1.54%)
$SPX : 6,909.51 (+0.69%)
SMCI : 32.42 (+0.81%)
MTCH : 31.83 (+3.71%)
$IUXX : 25,012.62 (+0.87%)
PFE : 26.65 (-0.78%)
MSFT : 397.23 (-0.31%)
ADBE : 258.61 (-0.23%)
AMD : 200.15 (-1.58%)
PFE
PFE Q4 CY2025 Deep Dive: Obesity Pipeline and Cost Discipline Face Post-COVID Headwinds StockStory - Tue Feb 3, 11:32PM CST

PFE Q4 CY2025 Deep Dive: Obesity Pipeline and Cost Discipline Face Post-COVID Headwinds

PFE : 26.65 (-0.78%)
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot